Reaction

Multi-Organ Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,960 reports · 38 co-occurring drugs

As of the last recalculation, Multi-Organ Disorder appears in 1,960 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 84.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Salmeterol Xinafoate	66	84.1	84.8
Esomeprazole Magnesium Capsule, Delayed Release	68	51.5	51.8
Esomeprazole Magnesium Delayed Release Capsules	68	51.5	51.8
Esomeprazole Magnesium Dihydrate	68	51.3	51.5
Rosuvastatin Calcium	101	40.1	40.2
Insulin Human	130	37.1	37.2
Isotretinoin	132	30.3	30.4
Valsartan Oral	137	28.7	28.8
Fluticasone Propionate And Salmeterol Xinafoate	105	19.6	19.6
Esomeprazole	104	18.7	18.8
Valsartan	144	15.6	15.6
Fluticasone Propionate Nasal	34	12.1	12.1
Insulin Lispro	144	11.9	11.9
Norepinephrine	11	11.0	11.0
Nevirapine	9	10.6	10.6
Norepinephrine Bitartrate	14	10.4	10.4
Desloratadine	10	9.9	10.0
Ganciclovir	9	9.4	9.4
Losartan	141	9.2	9.2
Ganciclovir Sodium	9	9.1	9.1
Thiotepa	8	8.9	8.9
Basiliximab	9	8.2	8.2
Tretinoin	6	7.9	7.9
Atorvastatin Calcium	160	7.4	7.4
Insulin Glargine	144	6.6	6.6
Vincristine Sulfate	18	6.6	6.6
Cytarabine	36	6.5	6.5
Remdesivir	8	6.4	6.4
Daptomycin	5	5.8	5.8
Agalsidase Beta	5	5.8	5.8
Amphetamine	4	5.1	5.1
Linezolid	14	5.0	5.0
Canakinumab	5	4.9	4.9
Durvalumab	7	3.7	3.7
Axicabtagene Ciloleucel	3	3.2	3.2
Ethyl Alcohol	8	3.1	3.1
Methoxy Polyethylene Glycol-Epoetin Beta	3	2.9	2.9
Adapalene	4	0.2	0.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.